
Mirum Pharmaceuticals Executives Sell Shares

I'm PortAI, I can summarize articles.
Executives of Mirum Pharmaceuticals, Michael G Grey and Saira Ramasastry, both 10% owners and directors, sold shares of the company. Grey sold 50,000 shares for $3.9 million, while Ramasastry sold 5,000 shares for $400,000. Both transactions were executed under a Rule 10b5-1 Plan. Following these sales, neither executive directly owns any common stock in the company.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

